Literature DB >> 16720588

A first look at the new Medicare prescription drug plans.

Austin B Frakt1, Steven D Pizer.   

Abstract

Medicare began offering an outpatient prescription drug benefit through private plans in January 2006. Using nationwide data, we examine the availability, costs, and benefits of regional and local plans offering these benefits to beneficiaries. Because they are an entirely new concept for Medicare, we focus on stand-alone prescription drug plans, comparing them with other Medicare health plans offering drug coverage. The infamous "doughnut hole" exists for all but a few of these plans. One national stand-alone drug plan, though, covers brand-name drugs with no gap. Variations in cost sharing and formularies provide beneficiaries with choices as well as complexity.

Entities:  

Mesh:

Year:  2006        PMID: 16720588     DOI: 10.1377/hlthaff.25.w252

Source DB:  PubMed          Journal:  Health Aff (Millwood)        ISSN: 0278-2715            Impact factor:   6.301


  6 in total

1.  Nothing for something? Estimating cost and value for beneficiaries from recent medicare spending increases on HMO payments and drug benefits.

Authors:  Steven D Pizer; Austin B Frakt; Roger Feldman
Journal:  Int J Health Care Finance Econ       Date:  2008-09-27

2.  Drug benefit changes under Medicare Advantage Part D: heterogeneous effects on pharmaceutical use and expenditures.

Authors:  Susan L Ettner; W Neil Steers; Norman Turk; Elaine S Quiter; Carol M Mangione
Journal:  J Gen Intern Med       Date:  2011-06-28       Impact factor: 5.128

3.  Impact of Medicaid preferred drug lists on therapeutic adherence.

Authors:  David B Ridley; Kirsten J Axelsen
Journal:  Pharmacoeconomics       Date:  2006       Impact factor: 4.981

4.  Entering and exiting the Medicare part D coverage gap: role of comorbidities and demographics.

Authors:  Susan L Ettner; Neil Steers; O Kenrik Duru; Norman Turk; Elaine Quiter; Julie Schmittdiel; Carol M Mangione
Journal:  J Gen Intern Med       Date:  2010-03-09       Impact factor: 5.128

5.  Patterns of prescription drug expenditures and medication adherence among medicare part D beneficiaries with and without the low-income supplement.

Authors:  Stella M Yala; Obidiugwu Kenrik Duru; Susan L Ettner; Norman Turk; Carol M Mangione; Arleen F Brown
Journal:  BMC Health Serv Res       Date:  2014-12-20       Impact factor: 2.655

6.  Angiotensin receptor blockers on the formularies of Medicare drug plans.

Authors:  Walid F Gellad; Haiden A Huskamp; Kathryn A Phillips; Jennifer S Haas
Journal:  J Gen Intern Med       Date:  2007-05-15       Impact factor: 5.128

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.